Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Delayed resolution of acute inflammation in ulcerative colitis is associated with elevated cytokine release downstream of TLR4.

Rahman FZ, Smith AM, Hayee B, Marks DJ, Bloom SL, Segal AW.

PLoS One. 2010 Mar 26;5(3):e9891. doi: 10.1371/journal.pone.0009891.

2.

Transcript levels of Toll-Like Receptors 5, 8 and 9 correlate with inflammatory activity in Ulcerative Colitis.

Sánchez-Muñoz F, Fonseca-Camarillo G, Villeda-Ramírez MA, Miranda-Pérez E, Mendivil EJ, Barreto-Zúñiga R, Uribe M, Bojalil R, Domínguez-López A, Yamamoto-Furusho JK.

BMC Gastroenterol. 2011 Dec 20;11:138. doi: 10.1186/1471-230X-11-138.

3.

Leukocyte toll-like receptor expression in end-stage kidney disease.

Gollapudi P, Yoon JW, Gollapudi S, Pahl MV, Vaziri ND.

Am J Nephrol. 2010;31(3):247-54. doi: 10.1159/000276764. Epub 2010 Jan 15.

PMID:
20090311
4.

TLR4 D299G polymorphism modulates cytokine expression in ulcerative colitis.

Meena NK, Verma R, Verma N, Ahuja V, Paul J.

J Clin Gastroenterol. 2013 Oct;47(9):773-80. doi: 10.1097/MCG.0b013e31828a6e93.

PMID:
23470644
5.

Inhibition of TIR domain signaling by TcpC: MyD88-dependent and independent effects on Escherichia coli virulence.

Yadav M, Zhang J, Fischer H, Huang W, Lutay N, Cirl C, Lum J, Miethke T, Svanborg C.

PLoS Pathog. 2010 Sep 23;6(9):e1001120. doi: 10.1371/journal.ppat.1001120.

6.

Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.

Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S.

Science. 2003 Aug 1;301(5633):640-3. Epub 2003 Jul 10.

7.

IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.

Strengell M, Lehtonen A, Matikainen S, Julkunen I.

J Leukoc Biol. 2006 Jun;79(6):1279-85. Epub 2006 Mar 21.

PMID:
16551679
8.

Recruitment of TLR adapter TRIF to TLR4 signaling complex is mediated by the second helical region of TRIF TIR domain.

Piao W, Ru LW, Piepenbrink KH, Sundberg EJ, Vogel SN, Toshchakov VY.

Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):19036-41. doi: 10.1073/pnas.1313575110. Epub 2013 Nov 5.

9.

Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation.

Esposito G, Capoccia E, Turco F, Palumbo I, Lu J, Steardo A, Cuomo R, Sarnelli G, Steardo L.

Gut. 2014 Aug;63(8):1300-12. doi: 10.1136/gutjnl-2013-305005. Epub 2013 Sep 30.

PMID:
24082036
10.

Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis.

Lundberg AM, Ketelhuth DF, Johansson ME, Gerdes N, Liu S, Yamamoto M, Akira S, Hansson GK.

Cardiovasc Res. 2013 Jul 15;99(2):364-73. doi: 10.1093/cvr/cvt033. Epub 2013 Feb 14.

PMID:
23417039
11.
12.

Toll-like receptor expression in chronic hepatitis C: correlation with pro-inflammatory cytokine levels and liver injury.

Riordan SM, Skinner NA, Kurtovic J, Locarnini S, McIver CJ, Williams R, Visvanathan K.

Inflamm Res. 2006 Jul;55(7):279-85.

PMID:
16955390
13.

In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands.

de Vos AF, Pater JM, van den Pangaart PS, de Kruif MD, van 't Veer C, van der Poll T.

J Immunol. 2009 Jul 1;183(1):533-42. doi: 10.4049/jimmunol.0802189.

14.

Contribution of interferon-beta to the murine macrophage response to the toll-like receptor 4 agonist, lipopolysaccharide.

Thomas KE, Galligan CL, Newman RD, Fish EN, Vogel SN.

J Biol Chem. 2006 Oct 13;281(41):31119-30. Epub 2006 Aug 15.

15.
16.

Toll like receptor (TLR)-4 as a regulator of peripheral endogenous opioid-mediated analgesia in inflammation.

Sauer RS, Hackel D, Morschel L, Sahlbach H, Wang Y, Mousa SA, Roewer N, Brack A, Rittner HL.

Mol Pain. 2014 Feb 6;10:10. doi: 10.1186/1744-8069-10-10.

17.

Transcriptome sequencing of microglial cells stimulated with TLR3 and TLR4 ligands.

Das A, Chai JC, Kim SH, Lee YS, Park KS, Jung KH, Chai YG.

BMC Genomics. 2015 Jul 10;16:517. doi: 10.1186/s12864-015-1728-5.

18.

Design and validation of a disease network of inflammatory processes in the NSG-UC mouse model.

Jodeleit H, Palamides P, Beigel F, Mueller T, Wolf E, Siebeck M, Gropp R.

J Transl Med. 2017 Dec 28;15(1):265. doi: 10.1186/s12967-017-1368-4.

19.

Toll/IL-1 domain-containing adaptor inducing IFN-β (TRIF) mediates innate immune responses in murine peritoneal mesothelial cells through TLR3 and TLR4 stimulation.

Hwang EH, Kim TH, Oh SM, Lee KB, Yang SJ, Park JH.

Cytokine. 2016 Jan;77:127-34. doi: 10.1016/j.cyto.2015.11.010. Epub 2015 Nov 12.

PMID:
26579632
20.

Supplemental Content

Support Center